Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma.
about
Insight to drug delivery aspects for colorectal cancerHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyNovel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasDurable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy.A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.Advances and Prospects in Cancer Immunotherapy
P2860
Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@en
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@nl
type
label
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@en
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@nl
prefLabel
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@en
Unsuccessful high dose IL-2 th ...... ssions in metastatic melanoma.
@nl
P2093
P356
P1476
Unsuccessful high dose IL-2 th ...... issions in metastatic melanoma
@en
P2093
Joseph J Drabick
Rebecca Gingrich
Salman Fateh
P304
P356
10.4161/CBT.10.11.13452
P577
2010-12-01T00:00:00Z